Dr. Jose Luis Avila, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1380 Ne Miami Gardens Dr, Suite 132, N Miami Beach, FL 33179 Phone: 305-956-7755 Fax: 305-956-5688 |
Florence Foucauld, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2020 Ne 163rd St Ste 203, N Miami Beach, FL 33162 Phone: 305-246-4607 Fax: 305-248-4715 |
News Archive
For women who have undergone mastectomy for breast cancer, breast reconstruction using the abdominal "DIEP flap" provides good long-term quality of life (QOL)—similar to that of women without breast cancer, reports a study in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Advanced Cell Technology, Inc. or "ACT" reported that a range of therapeutic cell types obtained from induced pluripotent stem (iPS) cells exhibit abnormal expansion and early cellular aging. The research, which appears online (published-ahead-of- print) in the journal STEM CELLS by ACT and its collaborators at Stem International (SCRMI), Harvard Medical School, and the University of Illinois, compares a variety of replacement cell types derived from human iPS cells with their embryonic stem (ES) cell counterparts. The findings support the use of ACT's single blastomere-derived human embryonic stem cell lines which do not display early aging.
A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer's disease, who attended the "Fourth Annual Meeting on Brain aging and Dementia - From successful aging to severe dementia", Held in Perugia in October 2006 under the auspices of the Italian Psychogeriatric Association, a member of the International Psychogeriatric Association, the meeting celebrates the centenary of Alzheimer's first description of the disease.
NanoViricides, Inc. announced that Inno-Haven LLC has completed acquisition of a light industrial building. The Company anticipates that it will be leasing a portion of this space, in the near future, for laboratory facilities and cGMP production of its nanoviricides® drug candidates against various viral diseases.
› Verified 8 days ago